Interestingly, this synergy was not observed in vitro, as combination treatment did not lead to a greater induction of IFN response genes compared with zotatifin alone (Supplemental Figure 7A), suggesting that the tumor immune microenvironment contributed to the response. This evidence concerns the gene IFNA1 and neoplasm.